I think it's something that is recognized by both internal medicine and nephrology is something that our

trainees should be learning. We just need to have the infrastructure to do it. And I think as, you know,

our generation of doctors kind of rises up, I think that infrastructure will grow further. But I honestly,

I can't imagine practicing without it. Welcome to Coriom. We have a special Neff Madness episode today,

and you just heard from Dr. Jeffrey Kot. Hi, my name is Jeffrey Kot. I'm a nephrologist and intensivist at Madler Hospital, which is part of the North Wales System on Long Island. And I'm also part of the Neffmanus Executive Committee. And I'm also here with Dr. Noah Markowitz. Hi, I'm Dr. Noah Markowitz, a PGI-Y-3 internal medicine resident at Montefiur and soon-to-be

Nephrology fellow at Mount Sinai. I'm personally beginning my own Pocus journey and I'm thrilled

to share some of the amazing teaching points we learned from Dr. Kot. Yes, and before we get started,

what is Neff Madness and what are we doing here today?

So Neff Madness is mirrored after the March Madness College Basketball Tournament.

And the goal is to award the topic that we think is going to be the face of nephrology in 26, the most influential or most exciting thing that's going to happen in the years to come.

So a bracket's going to be made of different concepts in nephrology, and these concepts will then go head to head with each other. The winner of

each matchup is decided by a panel of experts. I can say that I look forward to Neff Madness

every year because there's so much content released from it. Experts write blogs. Like I feel like

I go through a mini Nephrology fellowship every March.

And of course, there's the podcasts.

Yes, which is why we're here today.

So today we're talking about what is going head to head in the Northeast region

bracket, which is point of care ultrasound, Pocus.

And the matchup is between Pocus for Akii versusI. versus Pocus for end-stage renal disease.

So we're going to be going through four cases. The first two being Pocus for A.K.I. And the second two being Pocus for end-stage renal disease. So as we go through these cases, think about what you want to vote for as the future of nephrology.

All right. I think, Jeff, we're so excited to learn from you today and why you're so passionate about ultrasounds and kind of some of the cases that have made you think,

oh, I'm so glad I had these skills. And for listeners, all these cases are de-identified.

...